Results
897
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
897 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
E4C | €13.45 | 5.5% | -28.1% | €47.2m | €40.50 | PE31.2x | E46.7% | 3.5% | Telecom | ||
4434 | JP¥2,651.00 | -8.9% | -21.2% | JP¥20.8b | n/a | PE25.7x | E13.8% | n/a | Software | ||
6414 | NT$299.50 | -6.4% | 4.4% | NT$41.1b | NT$378.86 | PE17.8x | E20.6% | 3.8% | Tech | ||
MLAB | US$106.90 | -2.8% | -21.4% | US$600.6m | US$118.00 | PS2.7x | E138.5% | 0.6% | Pharmaceuticals & Biotech | ||
FEVR | UK£9.05 | -6.5% | -32.5% | UK£1.1b | UK£11.97 | PE68.6x | E34.2% | 1.8% | Food, Beverage & Tobacco | ||
GENL | UK£0.83 | -9.4% | -11.7% | UK£229.2m | UK£1.02 | PS3.5x | E53.4% | 0% | Energy | ||
MRVL | US$59.25 | -9.8% | -5.5% | US$54.6b | US$90.30 | PS9.6x | E59.2% | 0.4% | Semiconductors | ||
CWBC | US$19.31 | -4.4% | 14.1% | US$375.2m | US$23.75 | PB1x | E105.3% | 2.5% | Banks | ||
PION B | SEK 6.44 | 0.9% | -9.9% | SEK 310.3m | n/a | PB1.8x | E103.0% | 3.9% | Commercial Services | ||
BCHN | CHF 586.00 | -3.9% | 15.6% | CHF 2.0b | CHF 657.25 | PE22.1x | E9.1% | 2.6% | Capital Goods | ||
SOVO | US$22.98 | 1.0% | 63.4% | US$2.3b | US$23.00 | PE77.6x | E57.4% | n/a | Food, Beverage & Tobacco | ||
2851 | CN¥25.50 | 1.3% | -24.1% | CN¥12.8b | CN¥29.04 | PE21x | E24.0% | 0.9% | Capital Goods | ||
A036010 | ₩7,110.00 | -13.1% | -52.9% | ₩94.5b | ₩15,000.00 | PB0.8x | E65.5% | 0.7% | Tech | ||
EVER | US$24.83 | -6.3% | 267.8% | US$898.7m | US$29.12 | PS3.2x | E107.6% | n/a | Media | ||
QPR1V | €0.56 | -1.4% | 15.6% | €10.1m | n/a | PS1.4x | E70.1% | 0% | Software | ||
NEU | zł801.00 | -1.1% | 4.7% | zł3.6b | zł959.33 | PE23.1x | E23.2% | 1.8% | Healthcare | ||
300776 | CN¥47.96 | -3.6% | -18.8% | CN¥13.0b | CN¥55.93 | PE25.9x | E23.6% | 0.7% | Semiconductors | ||
SES | €98.70 | 0.1% | -4.5% | €1.5b | €153.63 | PE19.5x | E12.5% | 1.0% | Tech | ||
ACA | US$79.12 | -14.1% | 1.4% | US$4.4b | US$101.80 | PE26.2x | E22.0% | 0.3% | Capital Goods | ||
688293 | CN¥29.52 | 4.4% | -43.5% | CN¥3.4b | CN¥53.41 | PE68x | E48.6% | 1.6% | Pharmaceuticals & Biotech | ||
KIMLUN | RM 1.60 | -4.8% | 105.1% | RM 565.4m | RM 1.45 | PE78.7x | E56.7% | 0.6% | Capital Goods | ||
SOFF | NOK 40.56 | -5.0% | 79.2% | NOK 3.8b | n/a | PB2.2x | E126.2% | 0% | Energy | ||
LEVI | US$17.15 | -4.1% | 15.6% | US$7.1b | US$23.02 | PE47.4x | E39.3% | 2.8% | Consumer Durables | ||
1548 | HK$11.86 | -5.0% | -41.0% | HK$25.2b | HK$24.14 | PS3.8x | E97.9% | 0% | Pharmaceuticals & Biotech |